Syringomatous carcinoma in a young patient treated with Mohs micrographic surgery

Cutis

Volumn 77, Issue 1, 2006, Pages 19-24

  Hu, Jenny C ^a   Ko, Christine J ^b   Soriano, Teresa T ^a   Chiu, Melvin W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; KERATIN; TUMOR MARKER;

ADULT; CASE REPORT; CHEMISTRY; CHEMOSURGERY; DIFFERENTIAL DIAGNOSIS; EPIDERMOID CYST; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; REVIEW; SWEAT GLAND TUMOR; SYRINGOMA;

ADULT; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; EPIDERMAL CYST; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MOHS SURGERY; SWEAT GLAND NEOPLASMS; SYRINGOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 31944442273     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Weedon D. Tumors of cutaneous appendages. In: Weedon D, ed. Skin Pathology. 2nd ed. London, England: Churchill Livingstone; 2002:897.
2. Sanchez Yus E, Requena Caballero L, Garcia Salazar I, et al. Clear cell syringoid eccrine carcinoma. Am J Dermatopathol. 1987;9:225-231.
3. Freeman RG, Winkelmann RK. Basal cell tumor with eccrine differentiation (eccrine epithelioma). Arch Dermatol. 1969;100:234-242.
4. Glatt HJ, Proia AD, Tsoy EA, et al. Malignant syringoma of the eyelid. Ophthalmology. 1984;91:987-990.
5. Cooper PH, Mills SE, Leonard DD, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol. 1985;9:422-433.
6. Mehregan AH, Hashimoto K, Rahbari H. Eccrine adenocarcinoma: a clinicopathologic study of 35 cases. Arch Dermatol. 1983;119:104-114.
7. Wick MR, Goellner JR, Wolfe JT III, et al. Adnexal carcinomas of the skin, I: eccrine carcinomas. Cancer. 1985;56: 1147-1162.
8. Abenoza P, Ackerman AB. Syringomatous carcinomas. In: Abenoza P, Ackerman AB, eds. Neoplasms with Eccrine Differentiation. Philadelphia, Pa: Lea & Febiger; 1990:371-412.
9. Goto M, Sonoda T, Shibuya H, et al. Digital syringomatous carcinoma mimicking basal cell carcinoma. Br J Dermatol. 2001;144:438-439.
10. Urso C. Syringomatous breast carcinoma and correlated lesions. Pathologica. 1996;88:196-199.
11. Hoppenreijs VP, Reuser TT, Mooy CM, et al. Syringomatous carcinoma of the eyelid and orbit: a clinical and histopathological challenge. Br J Ophthalmol. 1997;81: 668-672.
12. Snow S, Madjar DD, Hardy S, et al. Microcystic adnexal carcinoma: report of 13 cases and review of the literature. Dermatol Surg. 2001;27:401-408.
13. Friedman PM, Friedman RH, Jiang SB, et al. Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol. 1999;41:225-231.
14. Antley CA, Carney M, Smoller BR. Microcystic adnexal carcinoma arising in the setting of previous radiation therapy. J Cutan Pathol. 1999;26:48-50.
15. Borenstein A, Seidman DS, Trau H, et al. Microcystic adnexal carcinoma following radiotherapy in childhood. Am J Med Sci. 1991;301:259-261.
16. Fleischmann HE, Roth RJ, Wood C, et al. Microcystic adnexal carcinoma treated by microscopically controlled excision. J Dermatol Surg Oncol. 1984;10:873-875.
17. Schwarze HP, Loche F, Lamant L, et al. Microcystic adnexal carcinoma induced by multiple radiation therapy. Int J Dermatol. 2000;39:369-372.
18. Cooper PH, Mills SE. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1984;10:908-914.
19. Hamm JC, Argenta LC, Swanson NA. Microcystic adnexal carcinoma: an unpredictable aggressive neoplasm. Ann Plast Surg. 1987;19:173-180.
20. Birkby CS, Argenyi ZB, Whitaker DC. Microcystic adnexal carcinoma with mandibular invasion and bone marrow replacement. J Dermatol Surg Oncol. 1989;15: 308-312.
21. Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52:295-300.
22. Gardner ES, Goldberg LH. Neglected microcystic adnexal carcinoma: the second reported case in a black patient. Dermatol Surg. 2001;27:678-680.
23. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer. 1982;50:566-572.
24. Sebastien TS, Nelson BR, Lowe L, et al. Microcystic adnexal carcinoma. J Am Acad Dermatol. 1993;29:840-845.
25. Kato H, Mizuno N, Nakagawa K, et al. Microcystic adnexal carcinoma: a light microscopic, immunohistochemical and ultrastructural study. J Cutan Pathol. 1990;17:87-95.
26. LeBoit PE, Sexton M. Microcystic adnexal carcinoma of the skin, a reappraisal of the differentiation and differential diagnosis of an underrecognized neoplasm. J Am Acad Dermatol. 1993;29:609-618.
27. Alessi E, Caputo R. Syringomatous carcinoma of the scalp presenting as a slowly enlarging patch of alopecia. Am J Dermatopathol 1993;15:503-505.
28. Malmusi M, Collina G. Syringoid eccrine carcinoma: a case report. Am J Dermatopathol. 1997;19:533-535.
29. Corredor F, Cohen PR, Tschen JA. Syringomatous changes of eccrine sweat ducts associated with prurigo nodularis. Am J Dermatopathol. 1998;20:296-301.
30. Amin SP, Herman AR, Busam KJ, et al. Multiple subclinical syringomatous proliferations encountered during Mohs surgery for basal cell carcinoma. Dermatol Surg. 2004;30:1420-1423; discussion 1423.
31. Saga K. Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors. J Investig Dermatol Symp Proc. 2001;6:49-53.
32. Penneys NS, Nadji M, Ziegels-Weissman J, et al. Carcinoembryonic antigen in sweat-gland carcinomas. Cancer. 1982;50:1608-1611.
33. Requena L, Marquina A, Alegre V, et al. Sclerosing-sweat-duct (microcystic adnexal) carcinoma-a tumor from a single eccrine origin. Clin Exp Dermatol. 1990;15:222-224.
34. Miyamoto T, Kambe N, Nishiura S, et al. Microcystic adnexal carcinoma: electron microscopic and immunohistochemical study. Dermatologica. 1990;180:40-43.
35. Smith KJ, Williams J, Corbett D, et al. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Am J Surg Pathol. 2001;25:464-471.
36. Kanitakis J, Zambruno G, Viac J, et al. Expression of neural-tissue markers (S-100 protein and Leu-7 antigen) by sweat gland tumors of the skin, an immunohistochemical study. J Am Acad Dermatol. 1987;17:187-191.
37. Chiller K, Passaro D, Scheuller M, et al. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. Arch Dermatol. 2000;136:1355-1359.
38. Abbate M, Zeitouni NC, Seyler M, et al. Clinical course, risk factors, and treatment of microcystic adnexal carcinoma: a short series report. Dermatol Surg. 2003;29:1035-1038.
39. Santa Cruz DJ. Sweat gland carcinomas: a comprehensive review. Semin Diagn Pathol. 1987;4:38-74.